** Shares of Medical device maker Vivos Therapeutics VVOS.O rise 10% to $1.65 premarket
** Co says it will distribute SoundHealth’s sleep and allergy devices, including an FDA-cleared wearable for nasal congestion and a new band that uses sound-based therapy to help users sleep
** Partnership also gives Vivos access to facial‑scanning and voice‑analysis tools to help screen patients for sleep disorders, per co
** Collaboration aims to widen access to non‑invasive treatments for sleep‑related breathing issues, which are often undiagnosed, co says
** Vivos develops devices for sleep apnea; SoundHealth builds AI‑powered health tools
** Shares down ~53% in 2025
(Reporting by Sahil Pandey in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))